Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, and Prostate Cancer Diagnosis and Treatment.
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.
Treatment-related changes in the prostate: past, present and future therapies.
Recent advances in liquid biopsy for genitourinary cancers: A narrative review.
Grading of bladder cancer: updates, controversies and practical solutions.
Molecular pathology of bladder cancer.
Urothelial Carcinoma in Children and Young Adults is Characterized by Higher Frequency of HRAS Mutations and Lower Prevalence of TERT Promoter and FGFR3 Mutations.
International Society of Urological Pathology (ISUP) Multidisciplinary Consensus Conference on Premalignant and Precursor Lesions of the Genitourinary Organs: Current Evidence and Future Directions.
Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.
ALK -Rearranged Renal Cell Carcinoma : Morphologic Spectrum and Genomic Landscape From a Multi-Institutional Cohort of 16 Cases.
Updates in bladder and prostate pathology: Diagnostic consensus and clinical relevance.
19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.
Urologic surgical pathology in the era of precision medicine.
Endometrial gastric (gastrointestinal)-type mucinous adenocarcinoma: Diagnostic criteria, differential diagnosis, and molecular insights.
HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity.
Renal cell tumours with papillary architecture: evolving concepts, classification and new emerging entities.
Patients review their pathology reports before their treating physician: heading towards patient autonomy? Focus on prostate cancer.
Genomic and clinicopathological characteristics of low oncotype recurrent score breast cancers with subsequent metastasis.
Marked attenuation of P63 expression in plasmacytoid urothelial carcinoma with expanded immunohistochemical framework including E-cadherin, P120, HER2 and TRPS1.
Clinical, pathological, and radiological features of the cystic renal lesions
The causal relationship between digital literacy and students’ academic achievement: a meta-analysis
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma.
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer
Urinary Tumor DNA–based Liquid Biopsy in Bladder Cancer Management: A Systematic Review
Effect of seawater curing on the mechanical properties of solidified high-water content marine dredged clay
Multi-omic analyses of the development of obesity-related depression linked to the gut microbe Anaerotruncus colihominis and its metabolite glutamate
SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway.
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study.
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.